Expression of transforming growth factor-β and type IV collagen in early streptozotocin-induced diabetes

Diabetes

Volumn 46, Issue 3, 1997, Pages 473-480

  Park, In Seok ^a   Kiyomoto, Hideyasu ^a   Abboud, Sherry L ^a   Abboud, Hanna E ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; INSULIN; MATRIX PROTEIN; PROCOLLAGEN; STREPTOZOCIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE EXPRESSION REGULATION; GLOMERULUS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY HYPERTROPHY; MALE; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT;

EID: 0031053824     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.3.473     Document Type: Article

References (46)

1. Mauer SM: Structural-functional correlations of diabetic nephropathy. Kidney Int 45:612-622, 1994
2. Ziyadeh FN: The extracellular matrix in diabetic nephropathy. Am J Kidney Dis 22:736-744, 1993
3. Adler S: Structure-function relationships associated with extracellular matrix alterations in diabetic glomerulopathy. J Am Soc Nephrol 5:1165-1172, 1994
4. Lane PH, Steffes MW, Mauer SM: Renal histologic changes in diabetes mellitus. Semin Nephrol 10:254-259, 1990
5. Osterby R, Parving HH, Nyberg G, Jorgensen H, Lokkegaard H, Svalander C: A strong correlation between glomerular filtration rate and surface in diabetic nephropathy. Diabetnlogia 31:265-270, 1988
6. Sharma K, Ziyadeh FN: The transforming growth factor-β system and the kidney. Semin Nephrol 13:116-128, 1993
7. Sharma K, Ziyadeh FN: The emerging role of transforming growth factor-β in kidney diseases. Am J Physiol 266:F829-F842, 1994
8. MacKay K, Kondiah P, Danielpour D, Austin III HA, Brown PD: Expression of transforming growth factor-β1 and β2 in rat glomeruli. Kidney Int 38:1096-1100, 1990
9. MacKay K, Striker L, Stauffer JW, Doi T, Agodoa LY, Striker GE: Transforming growth factor-β: murine glomerular receptors and responses of isolated glomerular cells. J Clin Invest 83:160-167, 1989
10. Jaffer F, Saunders C, Shultz P, Throckmorton D, Weinshell E, Abboud HE: Regulation of mesangial cell growth by polypeptide mitogens: inhibitory role of transforming growth factor β. Am J Pathol 135:261-269, 1989
11. Choi ME, Kim E, Huamg Q, Ballermann BJ: Rat mesangial cell hypertrophy in response to transforming growth factor β1. Kidney Int 44:948-958, 1993
12. Border WA, Okuda S, Languino LR, Ruoslahti E: Transforming growth factor-β regulates production of proteoglycans by mesangial cells. Kidney Int 37:689-695, 1990
13. Ziyadeh FN, Sharma K, Ericksen M, Wolf G: Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-β. J Clin Invest 93:536-542, 1994
14. Ishimura E, Bernd-Sterzel R, Kashgarian M: Effect of transforming growth factor-β on extracellular matrix production by cultured rat mesangial cells (Abstract). Kidney Int 37:197, 1990
15. Nakamura T, Okuda S, Ruoslahti E, Border WA: Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-β1. Kidney Int 41:1213-1221, 1992
16. Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature 346:371-374, 1990
17. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD, Rouslahti E: Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature Land 360:361-364, 1992
18. Nakamura T, Fukui M, Ebihara I, Osada S, Nagaoka I, Tomino Y, Koide H: mRNA expression of growth factors in glomeruli from diabetic rats. Diabetes 42:450-456, 1993
19. Miyazano K, Heldin C-H: Latent forms of TGF-β: molecular structure and mechanisms of activation. In Clinical Applications of TGF-β. Bock GR, Marsh J, Eds. Ciba Foundation Symposium. Chichester, U.K., Wiley, 1991, p. 81-92
20. Noble NA, Harper JR, Border WA; In vivo interactions of TGF-β and extracellular matrix. Prog Growth Factor Res 4:369-382, 1992
21. Massague J: The transforming growth factor-β family. Annu Rev Biol 6:597-641, 1990
22. Wolf G, Sharma K, Chen Y, Ericksen M, Ziyadeh FN: High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-β. Kidney Int 42:647-656, 1992
23. Rocco MV, Chen Y, Goldfarb S, Ziyadeh FN: Elevated glucose levels stimulate transforming growth factor-β gene expression and bioactivity in murine proximal tubule cell culture. Kidney Int 41:107-114, 1992
24. Sharma K, Ziyadeh FN: Renal hypertrophy is associated with upregulation of TGF-β1 gene expression in diabetic BB rat and NOD mouse. Am J Physiol 267:F1094-F1101, 1994
25. Shankland SJ, Scholey JW: Expression of transforming growth factor-β1 during diabetic renal hypertrophy. Kidney Int 46:430-442, 1994
26. Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA: Expression of transforming growth factor βis elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 90:1814-1818, 1993
27. Young BA, Johnson RJ, Alpers CE, Eng E, Gordon K, Floege J, Couser WG: Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int 47:935-944, 1995
28. Milani S, Herbst H, Schuppan D, Hahn EG, Stein H: In situ hybridization for procollagen types I, DT, and IV mRNA in normal and fibrotic rat liven evidence for predominant expression in nonparenchymal liver cells. Hepatology 10:84-92, 1989
29. Barnes JL, Hastings RR, De La Garza MA: Sequential expression of cellular fibronectin by platelets, macrophages, and mesangial cells in proliferative glomerulonephritis. Am J Pathol 145:585-597, 1994
30. Ayo SH, Radnick RA, Glass WF, Garoni JA, Rampt ER, Appling DR, Kreisberg JI: Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high-glucose medium. Am J Physiol 260:F185-F191, 1991
31. Nahman NS, Leonhart KL, Cosio FG, Hebert CL: Effects of high glucose on cellular proliferaton and fibronectin production by cultured human mesangial cells. Kidney Int 41:396-402, 1992
32. Pircher R, Jullien P, Lawrence DA: Transforming growth factor is stored in human blood platelets as a latent high molecular weight complex. Biochem Biophys Res Commun 136:30-37, 1986
33. Wakefield LM, Smith DM, Broz S, Jackson M, Levinson AP, Sporn MB: Recombinant TGF-β1 is synthesized as a two-compartment latent complex that shares some structural features with native platelet latent TGF-β1 complex. Growth Factors 1:203-218, 1989
34. Flaumenhaft R, Abe M, Sato Y, Miyazono K, Harpel J, Heldin K-H, Rifkin DB: Role of the latent TGF-β binding protein in the activation of latent TGF-β in cocultures of endothelial and smooth muscle cells. J Cell Biol 120:995-1002, 1993
35. Taipale J, Miyazono K, Heldin C-H, Keski-Oja J: Latent transforming growth factor-β1 associates to extracellular matrix via latent TGF-β binding protein. J Cell Biol 124:171-181, 1994
36. Yoshioka K, Takemura T, Murakami K, Okada M, Hino S, Miyamoto H, Maki S: Transforming growth factor-β protein and mRNA in glomeruli in normal and diseased human kidneys. Lab Invest 68:154-163, 1993
37. Sato Y, Tsuboi R, Lyons R, Moses H, Rifkin DB: Characterization of the activation of latent TGF-β by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self-regulating system. J Cell Biol 111:757-763, 1990
38. Sharma K, Jin Y, Guo J, Ziyadeh FN: Neutralization of TGF-β by anti-TGF-β antibody attenuates kidney hypertrophy and enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 45:522-530, 1996
39. Edwards DR, Murphy G, Reynolds JJ, Whitman SE, Docherty AJP, Angel P, Heath JK: Transforming growth factor βmodulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 6:1899-1904, 1987
40. Overall CM, Wrana JL, Sodek J: Independent regulation of collagenase, 72-kDa progelatinase and metalloendoproteinase inhibitor expresion in human fibroblasts by transforming growth factor-β. J Biol Chem 264:1860-1869, 1989
41. Falk RJ, Scheinmann JI, Mauer SM, Michael AF: Polyantigenic expansion of basement membrane constituents in diabetic nephropathy. Diabetes 32:34-39, 1983
42. Zhu D, Kim Y, Steffes MW, Groppoli TJ, Butkowski RJ, Mauer SM: Glomerular distribution of type IV collagen in diabetes by high resolution quantitative immunochemistry. Kidney Int 45:425-433, 1994
43. Kim Y, Kleppel M, Butkowski R, Mauer SM, Wieslander J, Michael AF: Differential expression of basement membrane collagen chains in diabetic nephropathy. Am J Pathol 138:413-420, 1991
44. Fukui M, Nakamura T, Ebihara I, Shirato I, Tomino Y, Koide H: ECM gene expression and its modulaton by insulin in diabetic rats. Diabetes 41:1520-1527, 1992
45. Ihm C-G, Lee GSL, Nast CC, Arushevsky A, Guillermo R, Levin PS, Glassock RJ, Adler SG: Early increased renal procollagen alphal(IV) mRNA levels in streptozotocin induced diabetes. Kidney Int 41:768-777, 1992
46. Poulsom R, Kurkinen M, Prockop DJ, Boot-Hanford RP: Increased steady-state levels of laminin B1 mRNA in kidneys of long-term streptozotocin-diabetic rats: no effect of an aldose reductase inhibitor. J Biol Chem 263:10072-10076, 1988